Christian Waage's Form 4 filing
Heron Therapeutics, Inc. (HRTX) · filed Dec 23, 2021
- Accession no.
- 0001209191-21-071172
- Filed
- Dec 23, 2021
- Trade date
- Dec 21-22, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.92K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christian WaageCIK 0001553179 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 | Common Stock | SSaleDisposed | −300 | $9.73F2 | −$2,919 | 3,200 | Direct | |
| Dec 22, 2021 | Common Stock | AGrant or awardAcquired | +10,452 | $0.00 | $0 | 13,652 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock | AGrant or awardAcquired | +20,903 | $0.00 | $0 | 20,903 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.